Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bridget E Crossman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Biology of the Cell|June 11, 2026
The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolismMathilda M Willoughby, Ankit Shroff, Bridget E Crossman, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolismMathilda M Willoughby, Ankit Shroff, Bridget E Crossman, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Cancers|March 28, 2025
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck CancerKourtney L Kostecki, Regan L Harmon, Mari Iida, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Journal of Molecular Sciences|May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast CancerMari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Frontiers in Oncology|May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Biology of the Cell|June 11, 2026
The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolismMathilda M Willoughby, Ankit Shroff, Bridget E Crossman, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
The ESCRT-0 protein HRS regulates hepatocellular lipid droplet catabolismMathilda M Willoughby, Ankit Shroff, Bridget E Crossman, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Cancers|March 28, 2025
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck CancerKourtney L Kostecki, Regan L Harmon, Mari Iida, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Journal of Molecular Sciences|May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast CancerMari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Frontiers in Oncology|May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 1